Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-10 Option Award |
2025-06-12 5:51 pm |
N/A N/A |
BeOne Medicines Ltd. | ONC | Ball Titus B. Principal Accounting Officer |
29,601 | $0 | 0 (Direct) |
View |
| 2025-06-10 Option Award |
2025-06-12 5:49 pm |
N/A 2035-06-09 |
BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel |
135,122 | $0 | 372,164 (Direct) |
View |
| 2025-06-10 Option Award |
2025-06-12 5:45 pm |
N/A 2035-06-09 |
BeOne Medicines Ltd. | ONC | Rosenberg Aaron Chief Financial Officer |
183,547 | $0 | 350,675 (Direct) |
View |
| 2025-06-10 Option Award |
2025-06-12 5:44 pm |
N/A 2035-06-09 |
BeOne Medicines Ltd. | ONC | Wang Lai Global Head of R&D |
248,924 | $0 | 1,952,834 (Direct) |
View |
| 2025-06-10 Option Award |
2025-06-12 5:42 pm |
N/A 2035-06-09 |
BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO |
355,615 | $0 | 1,522,906 (Direct) |
View |
| 2025-06-10 Exercise |
2025-06-12 5:39 pm |
N/A N/A |
BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd |
41,760 | $6.5 | 5,164,016 (Direct) |
View |
| 2025-06-10 Option Award |
2025-06-12 5:39 pm |
N/A 2035-06-09 |
BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd |
284,492 | $0 | 5,164,016 (Direct) |
View |
| 2025-06-10 Exercise |
2025-06-12 5:39 pm |
N/A 2025-07-19 |
BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd |
542,880 | $0 | 5,164,016 (Direct) |
View |
| 2025-06-10 Option Award |
2025-06-12 5:38 pm |
N/A 2035-06-09 |
BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer |
533,429 | $0 | 54,685,531 (Direct) |
View |
| 2025-06-10 Other |
2025-06-12 4:19 pm |
N/A N/A |
BeOne Medicines Ltd. | ONC | Yi Qingqing Director |
29,614 | $0 | 56,940 (Direct) |
View |
| 2025-05-21 Option Award |
2025-05-23 4:05 pm |
N/A 2035-05-20 |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
33,735 | $0 | 79,690 (Direct) |
View |
| 2025-05-21 Option Award |
2025-05-22 7:47 pm |
N/A 2035-05-20 |
BeiGene Ltd. | BGNE | Sharp Shalini Director |
33,735 | $0 | 41,886 (Direct) |
View |
| 2025-05-21 Option Award |
2025-05-22 7:46 pm |
N/A 2035-05-20 |
BeiGene Ltd. | BGNE | BRANDICOURT OLIVIER Director |
33,735 | $0 | 50,076 (Direct) |
View |
| 2025-05-21 Option Award |
2025-05-22 7:44 pm |
N/A 2035-05-20 |
BeiGene Ltd. | BGNE | Riva Alessandro Director |
33,735 | $0 | 79,690 (Direct) |
View |
| 2025-05-21 Option Award |
2025-05-22 7:44 pm |
N/A 2035-05-20 |
BeiGene Ltd. | BGNE | Dugan Margaret Director |
33,735 | $0 | 79,690 (Direct) |
View |
| 2025-05-21 Option Award |
2025-05-22 7:42 pm |
N/A 2035-05-20 |
BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director |
33,735 | $0 | 79,976 (Direct) |
View |
| 2025-05-21 Option Award |
2025-05-22 7:41 pm |
N/A 2035-05-20 |
BeiGene Ltd. | BGNE | HOOPER ANTHONY C Director |
33,735 | $0 | 87,490 (Direct) |
View |
| 2025-05-21 Option Award |
2025-05-22 4:10 pm |
N/A 2035-05-20 |
BeiGene Ltd. | ONC | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
112,970 | $0 | 9,058,960 (Indirect) |
View |
| 2025-05-13 Exercise |
2025-05-15 5:37 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
41,760 | $6.5 | 10,603,265 (Direct) |
View |
| 2025-05-13 Exercise |
2025-05-15 5:37 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
542,880 | $0 | 10,603,265 (Direct) |
View |
| 2025-05-09 Exercise |
2025-05-13 5:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
4,055,415 | $0.5 | 54,218,760 (Direct) |
View |
| 2025-05-09 Exercise |
2025-05-13 5:24 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
4,055,415 | $0 | 54,218,760 (Direct) |
View |
| 2025-05-09 Tax Withholding |
2025-05-13 5:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,990,603 | $17.85 | 54,218,760 (Direct) |
View |
| 2025-04-14 Exercise |
2025-04-16 5:12 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
41,760 | $6.5 | 11,146,145 (Direct) |
View |
| 2025-04-14 Exercise |
2025-04-16 5:12 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
542,880 | $0 | 11,146,145 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
35,444 | $174.43 | 1,488,482 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:04 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
674,973 | $0 | 1,488,482 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
16,477 | $119.96 | 1,488,482 (Direct) |
View |
| 2025-03-18 Exercise |
2025-03-20 4:53 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
41,760 | $6.5 | 11,689,025 (Direct) |
View |
| 2025-03-18 Exercise |
2025-03-20 4:53 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
542,880 | $0 | 11,689,025 (Direct) |
View |
| 2025-03-11 Gift |
2025-03-13 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
158,717 | $0 | 10,060,378 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
497,822 | $0.5 | 50,110,738 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
41,210 | $6.5 | 50,110,738 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 5:02 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,033,552 | $0 | 50,110,738 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-07 8:17 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
708,747 | $0.5 | 51,144,290 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-07 8:17 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
58,590 | $6.5 | 51,144,290 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-07 8:17 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,470,417 | $0 | 51,144,290 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-07 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
486,161 | $0.5 | 52,614,707 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-07 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
40,109 | $6.5 | 52,614,707 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
201,084 | $0 | 52,614,707 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-07 7:26 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,007,578 | $0 | 52,614,707 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 7:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
7,048 | $169.65 | 230,568 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 7:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
103,883 | $0 | 230,568 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 7:24 pm |
N/A 2028-04-29 |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
674,973 | $0 | 230,568 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 7:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
44,873 | $119.96 | 230,568 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 7:22 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
69,251 | $0 | 1,722,136 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 7:20 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Lee Chan Henry SVP, General Counsel |
40,209 | $0 | 246,142 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 7:19 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Rosenberg Aaron Chief Financial Officer |
48,581 | $0 | 167,128 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 4:59 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,220,531 | $0.5 | 53,627,732 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 4:59 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
101,000 | $6.5 | 53,627,732 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 4:59 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
2,533,531 | $0 | 53,627,732 (Direct) |
View |